Stress echocardiography identifies coronary artery disease in liver transplant candidates
David J. Plevak, – 30 December 2003
De novo hepatitis B infection after liver transplantation: Are all surgeons vaccinated against hepatitis B?
Rui Tato Marinho, Fernando Ramalho, José Velosa – 30 December 2003
Fulminant hepatic failure secondary to herpes simplex virus infection in a neonate: A case report of successful treatment with liver transplantation and perioperative acyclovir
Hiroto Egawa,, Yukihiro Inomata, Shingo Nakayama, Akira Matsui, Hirohiko Yamabe, Shinji Uemoto, Katsuhiro Asonuma, Koichi Tanaka – 30 December 2003 – Neonatal disseminated herpes simplex virus (HSV) infection, including fulminant hepatic failure (FHF), is lethal, and the patients rarely have a chance for liver transplantation because of the rapid development of the disease. We describe of a case of FHF secondary to HSV infection in a neonate successfully treated by aggressive intensive care followed by liver transplantation.
Hepatitis after liver transplantation: The role of the known and unknown viruses
Mario G. Pessoa, Norah A. Terrault, Linda D. Ferrell, Jill Detmer, Janice Kolberg, Mark L. Collins, Maurene Viele, John R. Lake, John P. Roberts, Nancy L. Ascher, Teresa L. Wright, – 30 December 2003 – This study was designed to determine the cause of posttransplantation hepatitis in patients undergoing transplantation for liver disease of nonviral cause; the role of acquired hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis G virus (HGV) in posttransplantation hepatitis; and the course of posttransplantation hepatitis of unknown cause.
Reverse transcriptase‐polymerase chain reaction fails to detect peripheral‐blood hepatitis C RNA in formalin‐fixed liver tissue
Rubén Bonilla Guerrero, Kenneth P. Batts, Jeffrey J. Germer, Rogelio G. Perez, Russell H. Wiesner, David H. Persing – 30 December 2003 – Currently, one of the major indications for liver transplantation is infection with hepatitis C virus (HCV). Many studies have suggested that recurrent infection with HCV is universal after transplantation. Fastidious techniques, such as reverse transcriptase‐polymerase chain reaction (RT‐PCR), have proved to be highly sensitive for detecting HCV RNA in serum and in fresh‐frozen and formalin‐fixed paraffin‐embedded (FFPE) liver tissue.
Dissection of an iliac artery conduit to liver allograft: Treatment with an endovascular stent
Moni Stein, Steven M. Rudich, Jonathan L. Riegler, Richard V. Perez, Daniel P. Link, John P. McVicar – 30 December 2003 – Hepatic artery thrombosis remains one of the most serious complications after orthotopic liver transplantation. Sepsis, biliary leakage and strictures, and retransplantation are often the result of this devastating complication. Because retransplantation or reoperation is sometimes not possible or advisable, other means of reestablishing hepatic artery continuity are desirable.
Basic principles of cerebral protection in humans
William L. Lanier – 30 December 2003
Fibrinolysis in patients with fulminant hepatic failure
M. Susan Mandell, Thomas Henthorn – 30 December 2003
Reducing the shortage of donor livers: What would it take to reliably split livers for transplantation into two adult recipients?
Steven M. Strasberg, Jeffrey A. Lowell, Todd K. Howard – 30 December 2003 – This article examines the scientific, technical, and administrative barriers to splitting donor livers for use in two adults. The main scientific barrier is that cadaveric donor livers at their current level of postoperative function are not sufficiently large to support life in two adult recipients. However, glycogenation of livers from young donors may be a method to overcome this problem in the short term.